Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
MORF - Morphic Holding, Inc.
Market Cap 2.69B P/E - EPS this Y -11.40% Ern Qtrly Grth -
Income -161.25M Forward P/E -14.60 EPS next Y -5.20% 50D Avg Chg 1.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 42.00%
Dividend N/A Price/Book 5.45 EPS next 5Y - 52W High Chg -7.00%
Recommedations 1.90 Quick Ratio 37.20 Shares Outstanding 50.09M 52W Low Chg 155.00%
Insider Own 16.76% ROA -21.46% Shares Float 36.85M Beta 1.42
Inst Own 90.11% ROE -29.59% Shares Shorted/Prior 6.25M/6.14M Price 58.69
Gross Margin - Profit Margin - Avg. Volume 478,482 Target Price 56.00
Oper. Margin - Earnings Date Aug 1 Volume 769,059 Change 1.45%
Healthcare | Biotechnology | United States
About Morphic Holding, Inc.

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical trials for the treatment of inflammatory bowel disease. The company's products in pipeline include Next Gen a4ß7 Inhibitors for additional potential GI indications, such as EGIDs, pouchitis, etc.; avß8 for the treatment of Myelofibrosis and solid tumor; and fibronectin integrin for pulmonary hypertensive. In addition, it has a license agreement with Janssen to discover and develop novel integrin therapeutics; collaboration agreement with Schrödinger for integrin targets; and license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Morphic Holding, Inc. News
05/01/24 Here's Why We're Not Too Worried About Morphic Holding's (NASDAQ:MORF) Cash Burn Situation
04/25/24 Morphic Holding Inc (MORF) Q1 2024 Earnings: A Detailed Review
04/25/24 Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
04/24/24 What Makes Morphic (MORF) a New Buy Stock
03/21/24 Morphic Holding Insiders Placed Bullish Bets Worth US$47.3m
03/19/24 Morphic Appoints Dr. Simon Cooper as Chief Medical Officer
04:05 PM Morphic to Participate in March Investor Conferences
02/26/24 Wall Street Analysts See a 56.18% Upside in Morphic Holding, Inc. (MORF): Can the Stock Really Move This High?
02/22/24 Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023
02/08/24 Wall Street Analysts Think Morphic Holding, Inc. (MORF) Could Surge 57.22%: Read This Before Placing a Bet
01/18/24 Morphic Holding Inc CEO Praveen Tipirneni Sells 13,923 Shares
09:55 AM Wall Street Analysts Believe Morphic Holding, Inc. (MORF) Could Rally 110.28%: Here's is How to Trade
01/03/24 Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference
12/20/23 Does Morphic Holding, Inc. (MORF) Have the Potential to Rally 92.88% as Wall Street Analysts Expect?
12/01/23 Wall Street Analysts See a 150.17% Upside in Morphic Holding, Inc. (MORF): Can the Stock Really Move This High?
11/23/23 We're Not Very Worried About Morphic Holding's (NASDAQ:MORF) Cash Burn Rate
11/15/23 Wall Street Analysts Think Morphic Holding, Inc. (MORF) Could Surge 160.84%: Read This Before Placing a Bet
11/10/23 Morphic to Present at November Investor Conferences
11/09/23 Morphic Holding, Inc. (MORF) Moves to Buy: Rationale Behind the Upgrade
11/03/23 Morphic Holding Inc (MORF) Reports Q3 2023 Loss of $36.2 Million, Ends Quarter with $725. ...
MORF Chatroom

User Image StockConsultant Posted - 2 days ago

$MORF Morphic stock moving higher off the 27.65 triple+ support area, https://stockconsultant.com/?MORF

User Image Stock_Titan Posted - 04/25/24

$MORF Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024 https://www.stocktitan.net/news/MORF/morphic-announces-corporate-highlights-and-financial-results-for-the-qi2utd041amk.html

User Image StockInvest_us Posted - 04/15/24

Signal alert: $MORF - Possible Runner https://stockinvest.us/l/1mBcvJi2ED

User Image piku99 Posted - 04/10/24

$MORF ahem ahem.. 🥳

User Image piku99 Posted - 04/10/24

$MORF deal imho

User Image Quantumup Posted - 03/13/24

Jefferies⬆️ $MORF $60 was $45/Buy~says stock is getting >interesting@ a $1.8B MCAP as it gets closer2 Ph2B UC data in 1H25 (expects +VE data); thinks the bar isn't high4 a safe oral pill w/ a proven MoA /proven comm success ( $tak Entyvio FY23 $5.6B); says MORF attractive@ $1.8B.

User Image Stock_Titan Posted - 1 month ago

$MORF Morphic to Participate in March Investor Conferences https://www.stocktitan.net/news/MORF/morphic-to-participate-in-march-investor-otk3qb3p15uy.html

User Image Germaneer Posted - 2 months ago

$MORF

User Image Stock_Titan Posted - 02/22/24

$MORF Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023 https://www.stocktitan.net/news/MORF/morphic-announces-corporate-highlights-and-financial-results-for-the-wzu4mnbu7meb.html

User Image S_Franconi Posted - 02/18/24

$MORF I like this.

User Image Strike_FOR Posted - 02/14/24

$LUMN $SFST $MORF $SPY

User Image swingingtech Posted - 02/14/24

$LUMN $SFST $MORF https://wallstreetwaves.com/best-momentum-stocks-to-buy-for-february-14th/

User Image swingingtech Posted - 02/14/24

$GLTO $LUMN $MORF $SFST https://wallstreetwaves.com/new-strong-buy-stocks-for-february-14th/

User Image StockInvest_us Posted - 02/08/24

Signal alert: $MORF - Overbought Trend Short (Overvalued) https://stockinvest.us/l/Jdi5z3CK8E

User Image FonsieTrader Posted - 02/07/24

$MORF perfect call

User Image StockInvest_us Posted - 2 months ago

Signal alert: $MORF - PivotPoint bottom https://stockinvest.us/l/wgAHMBZIfK

User Image StockConsultant Posted - 3 months ago

$MORF Morphic Holding stock awesome breakout, from Stocks To Watch , see https://stockconsultant.com/?MORF

User Image FonsieTrader Posted - 3 months ago

$MORF as expected

User Image mv21970 Posted - 01/25/24

$VTYX buying as much as i can under $2 and waiting for the expected bad news re VTX958 to buy full position, in 6-9 months the clueless analysts will start pumping VTX002 as potential best in class P3 asset for UC .. compared to $MORF for example which has a only one P2 asset for UC with similar efficacy and a market cap of $1.4b this is just too cheap to ignore imo

User Image cctranscripts Posted - 01/24/24

Statement of acquisition of beneficial ownership by individuals https://www.conferencecalltranscripts.org/summary/?id=12890137 $MORF

User Image tickeron Posted - 01/22/24

$MORF 5 Insiders at Morphic Holding sold 35,876 shares last week for $986.2K https://srnk.us/go/4975368

User Image MarketBeatInsiderTrades Posted - 01/18/24

Morphic General Counsel William Devaul Sells $123,952.41 in $MORF www.marketbeat.com/stocks/NASDAQ/MORF/insider-trades/

User Image MarketBeatInsiderTrades Posted - 01/18/24

Morphic CAO Robert Farrell Jr Sells $139,896.61 in $MORF www.marketbeat.com/stocks/NASDAQ/MORF/insider-trades/

User Image MarketBeatInsiderTrades Posted - 01/18/24

Morphic President Bruce Rogers Sells $173,571.86 in $MORF www.marketbeat.com/stocks/NASDAQ/MORF/insider-trades/

User Image MarketBeatInsiderTrades Posted - 01/18/24

Morphic CFO Marc Schegerin Sells $166,067.09 in $MORF www.marketbeat.com/stocks/NASDAQ/MORF/insider-trades/

User Image MarketBeatInsiderTrades Posted - 01/18/24

Morphic CEO Praveen Tipirneni Sells $382,743.27 in $MORF www.marketbeat.com/stocks/NASDAQ/MORF/insider-trades/

User Image risenhoover Posted - 01/17/24

Insider Tipirneni Praveen P. reports selling 13,923 shares of $MORF for a total cost of $382,753.02 https://fintel.io/n/us/morf/tipirneni-praveen-p?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image risenhoover Posted - 01/17/24

Insider Marc Schegerin reports selling 6,041 shares of $MORF for a total cost of $166,071.32 https://fintel.io/n/us/morf/schegerin-marc?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image risenhoover Posted - 01/17/24

Insider Bruce Rogers reports selling 6,314 shares of $MORF for a total cost of $173,576.28 https://fintel.io/n/us/morf/rogers-bruce?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image risenhoover Posted - 01/17/24

Insider Robert E Jr Farrell reports selling 5,089 shares of $MORF for a total cost of $139,900.17 https://fintel.io/n/us/morf/farrell-robert-e-jr?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

Analyst Ratings
Canaccord Genuity Buy Mar 8, 24
Citigroup Buy Dec 8, 23
BMO Capital Outperform Sep 28, 23
Stifel Hold Sep 25, 23
BTIG Neutral Sep 25, 23
Stifel Hold Aug 9, 23
Berenberg Buy Jul 21, 23
RBC Capital Outperform Apr 26, 23
BMO Capital Outperform Apr 26, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Tipirneni Praveen P. CEO CEO Jan 12 Sell 27.49 13,923 382,743 42,013 01/17/24
Tipirneni Praveen P. CEO CEO Jan 12 Option 0 42,000 55,936 01/17/24
SCHEGERIN MARC CFO and COO CFO and COO Jan 12 Sell 27.49 6,041 166,067 37,460 01/17/24
SCHEGERIN MARC CFO and COO CFO and COO Jan 12 Option 0 19,365 43,501 01/17/24
Rogers Bruce President President Jan 12 Sell 27.49 6,314 173,572 142,036 01/17/24
Rogers Bruce President President Jan 12 Option 0 20,295 148,350 01/17/24
Farrell Robert E Jr SVP Finance and CAO SVP Finance and CAO Jan 12 Sell 27.49 5,089 139,897 34,992 01/17/24
Farrell Robert E Jr SVP Finance and CAO SVP Finance and CAO Jan 12 Option 0 16,145 40,081 01/17/24
DeVaul William General Counsel and.. General Counsel and Secretary Jan 12 Sell 27.49 4,509 123,952 23,029 01/17/24
DeVaul William General Counsel and.. General Counsel and Secretary Jan 12 Option 0 14,200 27,538 01/17/24
Edwards Martin Director Director Nov 13 Buy 20.54 2,376 48,803 2,376 11/15/23
SCHEGERIN MARC CFO and COO CFO and COO Sep 07 Option 15 20,000 300,000 44,136 09/08/23
SCHEGERIN MARC CFO and COO CFO and COO Sep 07 Sell 54.06 20,000 1,081,200 24,136 09/08/23
Tipirneni Praveen P. President and CEO President and CEO Aug 01 Sell 57.23 3,597 205,856 13,936 08/03/23
Tipirneni Praveen P. President and CEO President and CEO Aug 01 Option 4.32 3,597 15,539 17,533 08/03/23
Tipirneni Praveen P. President and CEO President and CEO Jul 03 Sell 57.04 3,597 205,173 13,936 07/06/23
Tipirneni Praveen P. President and CEO President and CEO Jul 03 Option 4.32 3,597 15,539 17,533 07/06/23
Tipirneni Praveen P. President and CEO President and CEO Jun 12 Sell 63.01 840 52,928 13,936 06/14/23
Tipirneni Praveen P. President and CEO President and CEO Jun 12 Option 4.32 840 3,629 14,776 06/14/23
DeVaul William General Counsel and.. General Counsel and Secretary Jun 07 Sell 60.0492 7,756 465,742 13,338 06/09/23
Tipirneni Praveen P. President and CEO President and CEO Jun 01 Sell 57.18 3,597 205,676 13,936 06/02/23
Tipirneni Praveen P. President and CEO President and CEO Jun 01 Option 4.32 3,597 15,539 17,533 06/02/23
Farrell Robert E Jr SVP Finance and CAO SVP Finance and CAO May 23 Sell 60 10,000 600,000 23,708 05/25/23
Farrell Robert E Jr SVP Finance and CAO SVP Finance and CAO May 23 Option 4.32 10,000 43,200 33,708 05/25/23
DeVaul William General Counsel and.. General Counsel and Secretary May 23 Sell 60.02 3,902 234,198 21,094 05/25/23
Farrell Robert E Jr SVP Finance and CAO SVP Finance and CAO May 08 Option 4.32 11,486 49,620 23,708 05/10/23
Rogers Bruce President President May 05 Option 4.3151 16,000 69,042 133,055 05/09/23
Tipirneni Praveen P. President and CEO President and CEO May 03 Sell 51.11 3,597 183,843 13,936 05/05/23
Tipirneni Praveen P. President and CEO President and CEO May 03 Option 4.32 3,597 15,539 17,533 05/05/23
SPRINGER TIMOTHY A Director Director May 03 Buy 45.00 1,050,000 47,250,000 2,768,464 05/04/23
Farrell Robert E Jr SVP Finance and CAO SVP Finance and CAO Apr 25 Sell 54.71 10,000 547,100 12,222 04/27/23
Farrell Robert E Jr SVP Finance and CAO SVP Finance and CAO Apr 25 Option 4.32 10,000 43,200 22,222 04/27/23
Tipirneni Praveen P. President and CEO President and CEO Apr 25 Sell 53.4 25,179 1,344,559 13,936 04/27/23
Tipirneni Praveen P. President and CEO President and CEO Apr 25 Option 4.32 25,179 108,773 39,115 04/27/23
SCHEGERIN MARC CFO and COO CFO and COO Apr 25 Sell 54.71 50,000 2,735,500 24,136 04/27/23
SCHEGERIN MARC CFO and COO CFO and COO Apr 25 Option 15 50,000 750,000 74,136 04/27/23
Rogers Bruce President President Apr 25 Sell 53.4 30,000 1,602,000 117,055 04/27/23
Rogers Bruce President President Apr 25 Option 4.32 30,000 129,600 147,055 04/27/23
Farrell Robert E Jr SVP Finance and CAO SVP Finance and CAO Apr 20 Sell 45 10,000 450,000 12,222 04/21/23
Farrell Robert E Jr SVP Finance and CAO SVP Finance and CAO Apr 20 Option 4.32 10,000 43,200 22,222 04/21/23
Farrell Robert E Jr SVP Finance and CAO SVP Finance and CAO Apr 17 Sell 41.25 20,000 825,000 2,222 04/19/23
Farrell Robert E Jr SVP Finance and CAO SVP Finance and CAO Apr 17 Option 4.32 10,000 43,200 12,222 04/19/23
Rogers Bruce President President Apr 17 Sell 40.35 10,000 403,500 117,055 04/19/23
Rogers Bruce President President Apr 17 Option 4.32 10,000 43,200 127,055 04/19/23
SCHEGERIN MARC CFO and COO CFO and COO Mar 07 Sell 45 50,000 2,250,000 17,074 03/09/23
SCHEGERIN MARC CFO and COO CFO and COO Mar 07 Option 15 56,666 849,990 23,740 03/09/23
Rogers Bruce President President Feb 14 Sell 40.09 10,000 400,900 116,192 02/16/23
Rogers Bruce President President Feb 14 Option 4.32 10,000 43,200 126,192 02/16/23
DeVaul William General Counsel and.. General Counsel and Secretary Jan 13 Sell 30.63 1,169 35,806 23,739 01/18/23
Farrell Robert E Jr SVP Finance and CAO SVP Finance and CAO Jan 13 Sell 30.63 1,248 38,226 22,222 01/18/23